Literature DB >> 21899649

Adjuvant chemotherapy with TAC (docetaxel, doxorubicin, and cyclophosphamide) in patients with breast cancer--incidence of neutropenic fever outside clinical trials.

Jose L Passos-Coelho, Susana Esteves, Paula A Vieira, Miguel Isidoro, Manuel Ribeiro, João Oliveira, António R Moreira.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21899649     DOI： 10.1111/j.1524-4741.2011.01140.x

Source DB:  PubMed          Journal:  Breast J        ISSN： 1075-122X            Impact factor:   2.431


× No keyword cloud information.
  1 in total

1.  Comparison of effectiveness of biosimilar filgrastim (Nivestim™), reference Amgen filgrastim and pegfilgrastim in febrile neutropenia primary prevention in breast cancer patients treated with neo(adjuvant) TAC: a non-interventional cohort study.

Authors:  M Brito; S Esteves; R André; M Isidoro; A Moreira
Journal:  Support Care Cancer       Date:  2015-06-27       Impact factor: 3.603
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.